Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 3.200
-0.180 (-5.33%)
Oct 6, 2026, 6:26 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €20.54 million as of October 6, 2026. Its market cap has increased by 21.58% in one year.
Market Cap
20.54M
Enterprise Value
15.06M
Revenue
15.97M
Ranking
n/a
PE Ratio
20.65
Stock Price
€3.20
ChartMarket Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 20.54M, a decrease of -46.01%. That is a compound annual growth rate of -3.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 20.54M | 38.52% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.52B |
| Bayer Aktiengesellschaft | 44.15B |
| Siemens Healthineers AG | 42.14B |
| Fresenius SE & Co. KGaA | 24.58B |
| FamiCord AG | 54.04M |
| Pentixapharm Holding AG | 45.23M |
| MeVis Medical Solutions AG | 39.68M |
| aap Implantate AG | 24.20M |